(Q65471940)
Statements
Once-daily Oral Direct Factor Xa Inhibitor Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic Venous Thromboembolism in Patients With Symptomatic Deep-vein Thrombosis or Pulmonary Embolism. The Einstein-Extension Study (English)
0 references
February 2007
0 references
August 2009
0 references
1,197
0 references
18 year
0 references